Formerly regarded as a rare disease, bronchiectasis is increasingly recognised. A renewed
interest in this disease has led to significant progress in bronchiectasis research …

Abstract Purpose of Review Inhaled antifungals achieve high lung concentrations with
minimal systemic adverse events. Despite being available for over five decades, data …

Background Cystic fibrosis (CF), an inherited autosomal recessive disorder, is linked with
high morbidity and mortality rates due to bacteria, filamentous, yeast and black yeast‐like …

Background Allergic bronchopulmonary aspergillosis (ABPA) is thought to occur more
frequently in severe than in mild asthma. However, there are no precise data to support this …

Background Treatment of allergic bronchopulmonary aspergillosis (ABPA) is challenging.
Biological therapies have been reported as adjunctive treatments for ABPA, primarily in case …

Biologic medications target specific components of allergic and inflammatory pathways.
They are approved for the treatment of many atopic diseases such as asthma, nasal …

The pathogenesis of allergic bronchopulmonary aspergillosis (ABPA) remains poorly
understood, despite its widely accepted recognition as a distinct endotype of severe …

Observational studies indicate that Aspergillus colonization and allergic bronchopulmonary
aspergillosis (ABPA) in people with cystic fibrosis (CF) are associated with poorer lung …

Objectives Allergic bronchopulmonary aspergillosis (ABPA) is a complex lung disease
associated with significant morbidity. The ABPA Working Group (AWG) of the International …

A 91-year-old Chinese male was hospitalized on June 28, 2021, due to a sudden fever. The
patient had a long history of smoking, a 10-year history of type 2 diabetes, a family history of …